PAPER Sankar T, Lipsman N, Lozano AM
SEARCH RESULTS
330026 RESULTS
PAPER Sen N
Epigenetic Regulation of Memory by Acetylation and Methylation of Chromatin: Implications in Neurological Disorders, Aging, and Addiction.
Neuromolecular Med. 2014 Apr 29; PubMed: 24777294PAPER Moodley KK, Chan D
The hippocampus in neurodegenerative disease.
Front Neurol Neurosci. 2014;34:95-108. Epub 2014 Apr 16 PubMed: 24777134PAPER Nees F, Pohlack ST
Functional MRI studies of the hippocampus.
Front Neurol Neurosci. 2014;34:85-94. Epub 2014 Apr 16 PubMed: 24777133PAPER Lavenex P, Banta Lavenex P, Favre G
What animals can teach clinicians about the hippocampus.
Front Neurol Neurosci. 2014;34:36-50. Epub 2014 Apr 16 PubMed: 24777129PAPER Ragaliauskas T, Mickevicius M, Budvytyte R, Niaura G, Carbonnier B, Valincius G
Adsorption of β-amyloid oligomers on octadecanethiol monolayers.
J Colloid Interface Sci. 2014 Jul 1;425:159-67. Epub 2014 Mar 25 PubMed: 24776678PAPER Hales CM, Seyfried NT, Dammer EB, Duong D, Yi H, Gearing M, Troncoso JC, Mufson EJ, Thambisetty M, Levey AI, Lah JJ
U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.
Mol Neurodegener. 2014 Apr 28;9:15. PubMed: 24773620PAPER Conicella AE, Fawzi NL
The C-terminal threonine of Aβ43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils.
Biochemistry. 2014 May 20;53(19):3095-105. Epub 2014 May 7 PubMed: 24773532Hilary Heuer
UCSF Memory and Aging CenterSan Francisco, United States
Northeast ALS Consortium 2011
CONFERENCE 2011-10-26 00:00:00-2011-10-26 00:00:00 Fort Lauderdale, Florida, U.S.A. 26 October 2011 0
Gladstone Workshop: Apolipoprotein E and Alzheimer's Disease: Mechanisms and Therapeutic Strategies
CONFERENCE 2012-01-30 00:00:00-2012-02-01 00:00:00 Gladstone Institute of Neurological Disease, San Francisco, California, U.S.A. 30 January 2012 to 01 February 2012 This workshop will focus on the latest developments, controversies and most critical unresolved issues in this important and understudied fi
Keystone Symposium: Clinical and Molecular Biology of Acute and Chronic Traumatic Encephalopathies
CONFERENCE 2012-02-26 00:00:00-2012-03-02 00:00:00 Keystone Resort, Keystone, Colorado, U.S.A. 26 February 2012 to 02 March 2012 Acute traumatic brain injury (TBI) and its long-term neurodegenerative complications (known collectively as chronic traumatic encephalopathy, or CTE) are recognized increasingly
Keystone Symposium: Adult Neurogenesis
CONFERENCE 2011-01-09 00:00:00-2011-01-14 00:00:00 Sagebrush Inn and Conference Center, Taos, New Mexico, U.S.A. 09 January 2011 to 14 January 2011 The ability to generate new neurons in the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the hippocampal dentate gyrus
Keystone Symposium: ApoE, Alzheimer's, and Lipoprotein Biology
CONFERENCE 2012-02-26 00:00:00-2012-03-02 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 26 February 2012 to 02 March 2012 Apolipoprotein E4 (ApoE4) genotype is the primary risk factor for late-onset Alzheimer’s Disease. Approximately one fifth of the human population are ApoE4 carriers yet, more than 17
Thomas Bayer on Tg4-42
COMMENT The Tg4-42 model is the first, and currently only, model to express N-truncated human Aβ 4-42 without any other mutation, yet still develop neuronal loss and behavioral deficits. This is unique, because all other transgenic models that develop these patho
Current Filters
No filters selected